John Labella
About John Labella
John Labella is a Research Associate II at Tessera Therapeutics, where he has worked since 2020. He has a background in molecular biology and genetics, with previous roles at Cyteir Therapeutics and Editas Medicine.
Work at Tessera Therapeutics
John Labella has been employed as a Research Associate II at Tessera Therapeutics since 2020. He has contributed to various projects in the Greater Boston Area for a duration of four years. His role involves utilizing advanced gene editing techniques, including nucleofection and lipofection, to improve the efficacy of genetic constructs. Additionally, he prepares genomic DNA samples for sequencing on a Miseq platform and manages cell line stocks for the research team.
Previous Experience in Biotechnology
Prior to his current position, John Labella worked at Cyteir Therapeutics as an Associate Scientist from 2018 to 2020. He also served as a Cooperative Education Student - Molecular and Cell Biologist at Editas Medicine in 2017, where he was responsible for isolating genomic DNA using a Bravo robot for amplicon sequencing. His experience includes a role as a Research Assistant at Northeastern University in 2014 and as a Cooperative Education Student - Research Assistant at Pfizer in 2015.
Education and Expertise
John Labella studied at the University of Sydney, where he focused on Biology and Philosophy, achieving a minor in Ethics in 2016. He also holds a Bachelor of Science (BS) degree from Northeastern University, where he studied from 2013 to 2018. His educational background provides a strong foundation in biological sciences, complemented by his practical experience in various research roles.
Research Skills and Techniques
John Labella possesses expertise in advanced gene editing techniques, which he applies in his research. He is skilled in isolating genomic DNA and preparing samples for sequencing. His responsibilities also include managing and tracking cell line stocks, ensuring their maintenance and availability for experiments. These skills are critical for supporting the research objectives at Tessera Therapeutics.
Early Education
John Labella completed his high school education at Trumbull High School, where he focused on General Studies from 2009 to 2013. This foundational education set the stage for his future academic pursuits in the sciences and philosophy.